Arrhythmic Events and Mortality in Patients With Cardiogenic Shock on Inotropic Support: Results of the DOREMI Randomized Trial
Richard G. Jung(University of Ottawa), F. Daniel Ramirez(University of Ottawa), Michael J. Thibert(University of Ottawa), Jeffrey A. Marbach(Tufts Medical Center), Matthew C. Cheung(Simon Fraser University), Juan Russo(University of Ottawa), Nikita Malhotra(University of Ottawa), Jordan Hutson(University of Ottawa), Pablo B. Nery(University of Ottawa), Girish M. Nair(Ottawa Heart Institute), Rebecca Mathew(University of Ottawa), Shannon M. Fernando(University of Ottawa), Omar Abdel‐Razek(University of Ottawa), Pouya Motazedian(University of Ottawa), Pietro Di Santo(University of Ottawa), Trevor Simard(University of Ottawa), Simon Parlow(University of Ottawa), Benjamin Hibbert(Mayo Clinic), Willy Weng(University of Ottawa)
Cited by 7
Related Papers
Cardiac tumours: diagnosis and management
|The Lancet Oncology|2005|848
Radiofrequency Ablation vs Antiarrhythmic Drugs as First-Line Treatment of Paroxysmal Atrial Fibrillation (RAAFT-2)
|JAMA|2014|662
The Use of <sup>18</sup>F-FDG PET in the Diagnosis of Cardiac Sarcoidosis: A Systematic Review and Metaanalysis Including the Ontario Experience
|Journal of Nuclear Medicine|2012|512
Left Ventricular Unloading During Extracorporeal Membrane Oxygenation in Patients With Cardiogenic Shock
|Journal of the American College of Cardiology|2019|398
Association between complications and death within 30 days after noncardiac surgery
|Canadian Medical Association Journal|2019|348